FLIR and DARPA Sign Contract to Build Revolutionary Biological Warfare Combat Gear

Writer: Lois

Forward-Looking Infra-Red (FLIR) Systems, Inc announced on Monday its contract with the Pentagon’s Defense Advanced Research Projects Agency (DARPA) to develop an advanced anti-biological weapon and pathogen combat suit under the Personalised Protective Biosystems (PPB) program. The program aims to lessen the physiological burdens while integrating Personal Protective Equipment (PPE) features into a next-generation combat suit. From boots to gloves to vests, the gear will protect its wielder from various potential biological and chemical dangers, like chlorine gas and the Ebola virus.

FLIR, which also calls itself “The World’s Sixth Sense,” stated the suits would feature new kinds of fabric embedded with catalysts and chemistries capable of countering and reducing chemical and biological threats. The project already has $11.2 million in funding. The five-year contract is worth up to $20.5 million.

“With lives at stake, future operators wearing PPB suits will gain a major edge in staying protected from toxic chemicals and emerging biological threats such as dangerous viruses,” said FLIR Vice President and general manager of the Sensor Systems business, Mark Stock.

“We’re honoured DARPA has chosen us to lead this extraordinary and highly innovative effort to develop first-of-its-kind protective fabrics for our nation’s warfighters, health and public safety officials.”

The project demonstrates the Pentagon’s awareness of the need to protect soldiers on the battlefield from unseen bioweapon and chemical attacks. This protection is critical considering the likely laboratory origins of the COVID-19 pandemic. 

David Asher, the former US Department of State lead investigator who oversaw the White House COVID-19 task force, is among high-profile authorities who suspect the virus originated in a Wuhan Institute of Virology laboratory conducting bioweapons research.

ZeroHedge. (April 13, 2021). FLIR Wins DARPA Contract To Develop Next-Gen Combat Suits For Biowarfare.